We are able to create mammalian metabolites of more complex structures as featured in our May 2014 newsletter, here using using Cyclosporin A as an example. We do this using our microbial biotransformation and PolyCYPs enzymes. In addition, we are also able to produce microbial specific metabolites which may have interesting, exploitable properties that have not previously been possible to explore.
Q2 2026 – PROTAC MetID focus
Q2 2026 newsletter – PROTAC MetID focus From tackling the metabolism of PROTACs to synthesising oxidised metabolites, our latest newsletter features a MetID study undertaken
Read More >
